Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use.

Today, AARP, the Alzheimer’s Disease Data Initiative (AD Data Initiative), and the Institute for Health Metrics and Evaluation (IHME) at the University of Washington announced the Dementia Risk ...

New research suggests that eggs, a food often criticized for their high cholesterol content, could actually benefit cognitive ...

A look into diabetes and pregnancy and its effect on long-term cardiovascular health for the beginning of Diabetes Awareness Month.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

If you're over 40 and raise your levels of exercise to that of the top 25% of your peers, you might gain an average of five ...

A UB study found that heart disease and Type 2 diabetes were more common in redlined areas with reduced access to healthy ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.